HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?

Detalhes bibliográficos
Autor(a) principal: Filiponi, Thiago Corsi [UNIFESP]
Data de Publicação: 2013
Outros Autores: Durao, Marcelino de Souza [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1097/SHK.0b013e31828fafa6
http://repositorio.unifesp.br/handle/11600/36239
Resumo: Sepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1).
id UFSP_972439c3afcd80581254377cb38e4ce1
oai_identifier_str oai:repositorio.unifesp.br/:11600/36239
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?Sepsisrenal replacement therapydialysisSepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1).Universidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, BrazilHosp Israelita Albert Einstein, Renal Transplant Unit, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, BrazilWeb of ScienceLippincott Williams & WilkinsUniversidade Federal de São Paulo (UNIFESP)Hosp Israelita Albert EinsteinFiliponi, Thiago Corsi [UNIFESP]Durao, Marcelino de Souza [UNIFESP]2016-01-24T14:31:37Z2016-01-24T14:31:37Z2013-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion50-53http://dx.doi.org/10.1097/SHK.0b013e31828fafa6Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013.10.1097/SHK.0b013e31828fafa61073-2322http://repositorio.unifesp.br/handle/11600/36239WOS:000330251000011engShockinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2021-10-05T21:55:27Zoai:repositorio.unifesp.br/:11600/36239Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652021-10-05T21:55:27Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
title HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
spellingShingle HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
Filiponi, Thiago Corsi [UNIFESP]
Sepsis
renal replacement therapy
dialysis
title_short HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
title_full HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
title_fullStr HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
title_full_unstemmed HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
title_sort HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
author Filiponi, Thiago Corsi [UNIFESP]
author_facet Filiponi, Thiago Corsi [UNIFESP]
Durao, Marcelino de Souza [UNIFESP]
author_role author
author2 Durao, Marcelino de Souza [UNIFESP]
author2_role author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Hosp Israelita Albert Einstein
dc.contributor.author.fl_str_mv Filiponi, Thiago Corsi [UNIFESP]
Durao, Marcelino de Souza [UNIFESP]
dc.subject.por.fl_str_mv Sepsis
renal replacement therapy
dialysis
topic Sepsis
renal replacement therapy
dialysis
description Sepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1).
publishDate 2013
dc.date.none.fl_str_mv 2013-05-01
2016-01-24T14:31:37Z
2016-01-24T14:31:37Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1097/SHK.0b013e31828fafa6
Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013.
10.1097/SHK.0b013e31828fafa6
1073-2322
http://repositorio.unifesp.br/handle/11600/36239
WOS:000330251000011
url http://dx.doi.org/10.1097/SHK.0b013e31828fafa6
http://repositorio.unifesp.br/handle/11600/36239
identifier_str_mv Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013.
10.1097/SHK.0b013e31828fafa6
1073-2322
WOS:000330251000011
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Shock
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 50-53
dc.publisher.none.fl_str_mv Lippincott Williams & Wilkins
publisher.none.fl_str_mv Lippincott Williams & Wilkins
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268266888036352